New biosimilar dupilumab Look-Alike tested in healthy volunteers
Knowledge-focused
Not yet recruiting
This study checks if a new medicine called GLR1044 works the same as the approved drug Dupilumab (Dupixent®). It involves 198 healthy Chinese men who get one injection of either the new or the original drug. Researchers measure how the drug moves in the body and watch for side ef…
Phase: PHASE1 • Sponsor: Gan & Lee Pharmaceuticals. • Aim: Knowledge-focused
Last updated Apr 26, 2026 20:03 UTC